NASDAQ:HSCSW Heart Test Laboratories - HSCSW Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.17 -0.04 (-19.05%) (As of 03/30/2023 12:28 PM ET) Add Compare Share Share Today's Range$0.15▼$0.2850-Day Range$0.06▼$0.4252-Week Range$0.06▼$1.75Volume2,627 shsAverage Volume20,675 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media About Heart Test Laboratories (NASDAQ:HSCSW) StockHeart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Read More Receive HSCSW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address HSCSW Stock News HeadlinesMarch 17, 2023 | finanznachrichten.deHeart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial ResultsMarch 16, 2023 | finance.yahoo.comHeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial ResultsMarch 30, 2023 | Investor Place Media (Ad)The "King Of Quants" sees 10X potential...Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...March 6, 2023 | msn.comElite athletes with genetic heart disease can safely return to play with diagnosis and treatment, early study suggestsFebruary 6, 2023 | finance.yahoo.comHeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart DiseaseFebruary 3, 2023 | finance.yahoo.comHeartSciences Announces Further Internationalization of its Patent PortfolioJanuary 27, 2023 | seekingalpha.comHSCS Heart Test Laboratories, Inc.January 11, 2023 | msn.comDesert Valley Hospital’s Cardiac Cath Lab unveils new GE imaging SystemMarch 30, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastDecember 17, 2022 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Heart Test Laboratories, Inc. (HSCS)December 16, 2022 | finance.yahoo.comHeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial ResultsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HSCSW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HSCSW CUSIPN/A CIK1468492 Webheartsciences.com Phone682-237-7781FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$9,299.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Andrew Simpson (Age 53)CEO, Pres & Chairman of Directors Mr. Mark T. Hilz (Age 63)COO, Sec. & Director Comp: $104.17kMs. Danielle Watson (Age 40)CFO & Treasurer Key CompetitorsenVVeno MedicalNASDAQ:NVNOW111NASDAQ:YIAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlopexxNASDAQ:ALPXView All Competitors HSCSW Stock - Frequently Asked Questions How have HSCSW shares performed in 2023? Heart Test Laboratories' stock was trading at $0.2852 on January 1st, 2023. Since then, HSCSW stock has decreased by 26.4% and is now trading at $0.21. View the best growth stocks for 2023 here. What is Heart Test Laboratories' stock symbol? Heart Test Laboratories trades on the NASDAQ under the ticker symbol "HSCSW." How do I buy shares of Heart Test Laboratories? Shares of HSCSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Heart Test Laboratories' stock price today? One share of HSCSW stock can currently be purchased for approximately $0.21. How can I contact Heart Test Laboratories? The official website for the company is heartsciences.com. The company can be reached via phone at 682-237-7781. This page (NASDAQ:HSCSW) was last updated on 3/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.